ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 727357 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 727357; 2) Community: the network communities that were significantly associated with the response to NSC 727357; 3) Molecule: the relationships between components within communities and NSC 727357; 4) MDR: the compounds that were significantly associated with the NSC 727357.

NSC Compound Enrichment Correlation
NSC 694509 Null 0.022188614181866 0.19949548
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.022188614181866 0.16885905
NSC 701022 Null 0.022188614181866 0.13744773
NSC 718630 Null 0.022188614181866 0.44684401
NSC 726217 Combretastatin A4-analogue 0.022188614181866 0.30212239
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.022188614181866 0.37859759
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.022188614181866 0.36671428
NSC 732205 Null 0.022188614181866 0.36283647
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.022188614181866 0.19983492
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.022188614181866 0.10729622
Total:67  Current:34    [First] [Prev] [Next] [Last]